DE1695357A1 - Verfahren zur Herstellung neuer Verbindungen aus Hydroxocobalamin und Aminosaeuren mit Jodarylalkylearbonsaeurestruktur - Google Patents

Verfahren zur Herstellung neuer Verbindungen aus Hydroxocobalamin und Aminosaeuren mit Jodarylalkylearbonsaeurestruktur

Info

Publication number
DE1695357A1
DE1695357A1 DE19671695357 DE1695357A DE1695357A1 DE 1695357 A1 DE1695357 A1 DE 1695357A1 DE 19671695357 DE19671695357 DE 19671695357 DE 1695357 A DE1695357 A DE 1695357A DE 1695357 A1 DE1695357 A1 DE 1695357A1
Authority
DE
Germany
Prior art keywords
hydroxocobalamin
production
new compounds
amino acids
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19671695357
Other languages
German (de)
English (en)
Inventor
Thullier Melle Yvonne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROLLAND LAB A
Laboratoires Albert Rolland SA
Original Assignee
ROLLAND LAB A
Laboratoires Albert Rolland SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROLLAND LAB A, Laboratoires Albert Rolland SA filed Critical ROLLAND LAB A
Publication of DE1695357A1 publication Critical patent/DE1695357A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE19671695357 1966-02-10 1967-02-10 Verfahren zur Herstellung neuer Verbindungen aus Hydroxocobalamin und Aminosaeuren mit Jodarylalkylearbonsaeurestruktur Pending DE1695357A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR49062A FR5372M (xx) 1966-02-10 1966-02-10

Publications (1)

Publication Number Publication Date
DE1695357A1 true DE1695357A1 (de) 1972-02-24

Family

ID=8600993

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19671695357 Pending DE1695357A1 (de) 1966-02-10 1967-02-10 Verfahren zur Herstellung neuer Verbindungen aus Hydroxocobalamin und Aminosaeuren mit Jodarylalkylearbonsaeurestruktur

Country Status (10)

Country Link
US (1) US3459855A (xx)
BE (1) BE693038A (xx)
CH (1) CH471139A (xx)
DE (1) DE1695357A1 (xx)
FI (1) FI47191C (xx)
FR (1) FR5372M (xx)
GB (1) GB1123853A (xx)
LU (1) LU52920A1 (xx)
NL (1) NL6701970A (xx)
SE (1) SE333934B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624303A (en) * 1970-03-09 1971-11-30 Motorola Inc Signal-demodulating phase control system
US3981863A (en) * 1975-02-25 1976-09-21 Micromedic Diagonistics, Inc. Cyanocobalamin derivatives
US4209614A (en) * 1978-05-30 1980-06-24 E. R. Squibb & Sons, Inc. Vitamin B12 derivative suitable for radiolabeling
DE3262956D1 (en) * 1981-06-22 1985-05-15 Technicon Instr Labelled vitamin b12 derivatives, their preparation and use
NZ217821A (en) * 1985-10-10 1989-07-27 Biotech Australia Pty Ltd Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
US5807832A (en) * 1987-06-09 1998-09-15 Biotech Australia Pty Limited Oral delivery of biologically active substances bound to vitamin B12
ATE156705T1 (de) * 1991-04-02 1997-08-15 Biotech Australia Pty Ltd Systeme zur oralen freisetzung von mikropartikeln

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2748054A (en) * 1951-10-16 1956-05-29 Olin Mathieson Stable vitamin b12 and soluble folic acid salt mixture
US3035983A (en) * 1958-07-18 1962-05-22 Distillers Co Yeast Ltd Process for the production of cobalamin/peptide compositions
US3035974A (en) * 1960-02-18 1962-05-22 Israel Murray Compositions and method for the parenteral administration of thyroxine

Also Published As

Publication number Publication date
BE693038A (xx) 1967-07-03
FI47191C (fi) 1973-10-10
US3459855A (en) 1969-08-05
FR5372M (xx) 1967-10-16
FI47191B (xx) 1973-07-02
NL6701970A (xx) 1967-08-11
LU52920A1 (xx) 1967-04-03
SE333934B (xx) 1971-04-05
GB1123853A (en) 1968-08-14
CH471139A (fr) 1969-04-15

Similar Documents

Publication Publication Date Title
CH635823A5 (de) Verfahren zur herstellung von neuen 1-amidin-3-substituierten-phenylharnstoffen.
DE2527914A1 (de) Vincaminverbindungen, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische mittel
DE1695357A1 (de) Verfahren zur Herstellung neuer Verbindungen aus Hydroxocobalamin und Aminosaeuren mit Jodarylalkylearbonsaeurestruktur
DE3016752A1 (de) Verfahren zur herstellung von 2-isopropylaminopyrimidinhydroxy-derivaten
DE2632118C3 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
DE1916055A1 (de) Aminoketone,ihre Verwendung und Verfahren zur Herstellung derselben
DE1813918C3 (de) 2-Hydroxymethyl-3-carbonsäureamido--chinoxalin-M-di-N-oxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
DE1620177C3 (de) N-(2-Hydroxyäthyl)-piperazinocarboxymethyl-tetracyclin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1900772A1 (de) Dimethylbiguanidderivat
DE2264938A1 (de) 3-arylaminocarbonyl-4-hydroxy-benzo eckige klammer auf b eckige klammer zu thiacyclohex(3)en-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2738498B2 (de) l-(2-Chloräthyl)-l-nitroso-3-<2- acetamido-2desoxy- ß -D-glucopyranosyl)- harnstoffe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1041038B (de) Verfahren zur Herstellung von wenig toxischen Salzen von basischen Streptomyces-Antibiotika
DE2629133C2 (de) 5"-Amino-3',5"-didesoxyribostamycin, Verfahren zu dessen Herstellung sowie antimikrobielle Zubereitungen
DE2748794C2 (de) Malonylharnstoffkomplexe, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE1695043C2 (de) Pharmazeutische Zusammensetzungen mit sedativen und tranquillisierenden Eigenschaften
DE963514C (de) Verfahren zur Herstellung schwerloeslicher kristallisierter Streptomycin- und Dihydrostreptomycinsalze
DE1668659C3 (de) Neue Derivate von 2 a, 3 a- Epithioandrostan, Verfahren zu ihrer Herstellung sowie diese enthaltende Mittel
DD142653A5 (de) Herstellungsmethode eines szintillographischen mittels
DE3046927A1 (de) 8-dialkylaminoalkylaether-coffein-platin-komplexe , verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2226298C3 (de) 3-Arylaminocarbonyl-4-hydroxybenzo eckige Klammer auf b eckige Klammer zu thiacyclohex(3)en-1,1-dioxide, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1593970C3 (de) Homoargininpolymere und Verfahren zu ihrer Herstellung
DE2052819C3 (de) Cytosininosinat, Verfahren zu dessen Herstellung und es enthaltende Arzneimittel
DE2301394C3 (de) l,2-Diphenyl-3,5-dioxo-4-n-butylpyrazolidinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1695781C3 (de) Psychotropes Arzneimittel
DE2338350A1 (de) Beta-(3,4-dialkanoyloxyphenyl)-lalanin-ester

Legal Events

Date Code Title Description
OHN Withdrawal